欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号PL/H/0500/002
药品名称Rosuvastatin/EzetimibeTeva
活性成分
    • Ezetimibe 10.0 mg
    • Rosuvastatin 10.0 mg
剂型Tablet
上市许可持有人Teva B.V. Swensweg 5 2031 GA Haarlem Netherlands
参考成员国 - 产品名称Poland (PL)
Rosuvastatin/Ezetimibe Teva
互认成员国 - 产品名称
    • Austria (AT)
    • Belgium (BE)
      Ezetimibe/Rosuvastatine Teva 10 mg/10 mg tabletten
    • Finland (FI)
    • Italy (IT)
    • Bulgaria (BG)
      Tintaros Plus
    • Czechia (CZ)
      Ezetimibe/Rosuvastatin Teva
    • Croatia (HR)
      Eprizet 10 mg/10 mg tablete
许可日期2018/01/15
最近更新日期2025/02/07
药物ATC编码
    • C10BA06 rosuvastatin and ezetimibe
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Multiple (Copy) Application
  • TypeLevel3:Fixed combination Art 10b Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase